Open Label, Randomized, Single Center, 2-Way Crossover Bioequivalence Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule 40 mg D961H After Repeated Oral Administration in Japanese Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Esomeprazole (Primary)
- Indications Bleeding ulcer; Gastro-oesophageal reflux; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 11 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2009 New trial record